Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2025-12-24 @ 2:55 PM
NCT ID:
NCT04389359
Eligibility Criteria:
Inclusion Criteria:
* Have no previous confirmed COVID-19 diagnosis
* Fall into one of the high risk population groups
Exclusion Criteria:
* Inability to provide informed consent
* Symptomatic for possible COVID-19 at baseline or symptoms highly suggestive of COVID-19 experienced since 1st March 2020
* Hypersensitivity reaction to hydroxychloroquine, chloroquine or 4-aminoquinolines or any formulation excipients
* Contraindication to taking hydroxychloroquine as prophylaxis e.g known epilepsy
* Already taking chloroquine, hydroxychloroquine or 4-aminoquinolines
* History of any retinopathy including diabetic retinopathy requiring laser therapy
* Taking medications which are contra-indicated alongside HCQ - Digoxin, Halofantrine, Amiodarone, Moxifloxacin, Cyclosporin, Mefloquine, Praziquantel, Tamoxifen
* Known history of prolonged QTc
* Type I diabetes or insulin-dependent type II diabetes
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04389359
Study Brief:
Protocol Section:
NCT04389359